{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:36:30Z","timestamp":1792146990154,"version":"4.4.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":2995,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA163217"],"award-info":[{"award-number":["CA163217"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE018304"],"award-info":[{"award-number":["DE018304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA066529"],"award-info":[{"award-number":["CA066529"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ajpath.2011.06.017","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T17:05:15Z","timestamp":1312477515000},"page":"2108-2119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Phosphatase and Tensin Homolog on Chromosome 10 Is Phosphorylated in Primary Effusion Lymphoma and Kaposi's Sarcoma"],"prefix":"10.1016","volume":"179","author":[{"given":"Debasmita","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk P.","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.06.017_bib1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.06.017_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00000478-199911000-00010","article-title":"Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus","volume":"23","author":"Matsushima","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.leu.2401390","article-title":"Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8","volume":"13","author":"Dotti","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2011.06.017_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib5","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood.V90.3.1186.1186_1186_1191","article-title":"Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus\/human herpesvirus-8","volume":"90","author":"Horenstein","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib6","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.06.017_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.06.017_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archderm.144.5.692","article-title":"Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment","volume":"144","author":"Guenova","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib9","first-page":"306","article-title":"Simultaneous Hodgkin's disease and Kaposi sarcoma in a renal transplant recipient","volume":"21","author":"Yaich","year":"2010","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.ajpath.2011.06.017_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-0012.2009.01132.x","article-title":"Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient","volume":"24","author":"Ho","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajpath.2011.06.017_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-3046.2008.00944.x","article-title":"Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus","volume":"13","author":"Yuksekkaya","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ajpath.2011.06.017_bib12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.intimp.2006.09.018","article-title":"Reccurence of Kaposi's sarcoma after increased exposure to sirolimus","volume":"6","author":"Boraty\u0144ska","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib13","doi-asserted-by":"crossref","first-page":"825093","DOI":"10.1155\/2008\/825093","article-title":"Targeting mTOR in HIV-negative classic Kaposi's sarcoma","volume":"2008","author":"Merimsky","year":"2008","journal-title":"Sarcoma"},{"key":"10.1016\/j.ajpath.2011.06.017_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-3062.2007.00239.x","article-title":"Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod","volume":"10","author":"Babel","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajpath.2011.06.017_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1600-6143.2007.02110.x","article-title":"Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin","volume":"8","author":"Boulanger","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajpath.2011.06.017_bib16","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/01.tp.0000203322.99037.d2","article-title":"No effect of sirolimus for Kaposi sarcoma in a renal transplant recipient","volume":"81","author":"Descoeudres","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.ajpath.2011.06.017_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/TP.0b013e3181b15d56","article-title":"Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients","volume":"88","author":"Barozzi","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ajpath.2011.06.017_bib18","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1517\/14656566.2.11.1903","article-title":"Sirolimus: a comprehensive review","volume":"2","author":"Kahan","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajpath.2011.06.017_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2011.06.017_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The Akt-mTOR tango and its relevance to cancer","volume":"8","author":"Hay","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2011.06.017_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2011.06.017_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2011.06.017_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2011.06.017_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2006.03.028","article-title":"The PTEN and INK4A\/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2011.06.017_bib25","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma","volume":"5","author":"Cloughesy","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajpath.2011.06.017_bib26","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood.V96.10.3560","article-title":"Loss of PTEN expression leading to high Akt activation in human multiple myelomas","volume":"96","author":"Hyun","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib27","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.06.017_bib28","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR","volume":"98","author":"Neshat","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.06.017_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2011.06.017_bib30","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1038\/onc.2008.49","article-title":"Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors","volume":"27","author":"Steelman","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2011.06.017_bib31","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1128\/MCB.00310-08","article-title":"PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression","volume":"28","author":"Chang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib32","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1158\/0008-5472.CAN-07-1263","article-title":"Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2006.02.024","article-title":"Regulation of the PTEN phosphatase","volume":"374","author":"Gericke","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.ajpath.2011.06.017_bib34","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1158\/0008-5472.CAN-06-0419","article-title":"Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo","volume":"66","author":"Wendel","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib35","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","article-title":"Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling","volume":"109","author":"Sin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1385\/CBB:40:3:305","article-title":"Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8)","volume":"40","author":"Damania","year":"2004","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.ajpath.2011.06.017_bib37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4161\/cc.6.4.3843","article-title":"Akt\/TSC\/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma","volume":"6","author":"Montaner","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajpath.2011.06.017_bib38","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JVI.78.4.1918-1927.2004","article-title":"The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway","volume":"78","author":"Tomlinson","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib39","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood.V91.5.1671","article-title":"Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod\/SCID mice","volume":"91","author":"Boshoff","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib40","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V86.7.2708.2708","article-title":"In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences","volume":"86","author":"Cesarman","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib41","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1182\/blood.V88.7.2648.bloodjournal8872648","article-title":"Establishment and characterization of a primary effusion (body cavity- based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8) in the absence of Epstein-Barr virus","volume":"88","author":"Arvanitakis","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib42","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20031467","article-title":"KSHV vFLIP is essential for the survival of infected lymphoma cells [Erratum appeared in J Exp Med 2006, 203:1383]","volume":"199","author":"Guasparri","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2011.06.017_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00042560-199611010-00003","article-title":"The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions","volume":"13","author":"Komanduri","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib44","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2002-08-2525","article-title":"Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B","volume":"101","author":"Ghosh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib45","first-page":"276","article-title":"Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma","volume":"22","author":"Menezes","year":"1975","journal-title":"Biomedicine"},{"key":"10.1016\/j.ajpath.2011.06.017_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ijc.2910190105","article-title":"Establishment in continuous culture of a new type of lymphocyte from a \u201cBurkitt like\u201d malignant lymphoma (line D.G.-75)","volume":"19","author":"Ben-Bassat","year":"1977","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2011.06.017_bib47","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.onc.1201699","article-title":"A transforming p53 mutant, which binds DNA, transactivates and induces apoptosis reveals a nuclear: cytoplasmic shuttling defect","volume":"16","author":"Crook","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2011.06.017_bib48","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1128\/JVI.74.21.10187-10193.2000","article-title":"A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant","volume":"74","author":"Cannon","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib49","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<394::AID-JMV12>3.0.CO;2-H","article-title":"Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma","volume":"58","author":"Katano","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib50","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4049\/jimmunol.165.4.2077","article-title":"Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus","volume":"165","author":"Brander","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib51","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/gut.2007.142927","article-title":"Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis","volume":"57","author":"van Hattem","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2011.06.017_bib52","first-page":"3369","article-title":"The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival","volume":"9","author":"Zhou","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib53","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1128\/JVI.01321-09","article-title":"Distinct p53, p53: LANA, and LANA complexes in Kaposi's sarcoma-associated herpesvirus lymphomas","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-9378-2-7","article-title":"The AIDS and Cancer Specimen Resource: role in HIV\/AIDS scientific discovery","volume":"2","author":"Ayers","year":"2007","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ajpath.2011.06.017_bib55","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1158\/0008-5472.CAN-03-3835","article-title":"The tumor microenvironment controls primary effusion lymphoma growth in vivo","volume":"64","author":"Staudt","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcdb.2003.12.021","article-title":"Human cancer, PTEN and the PI-3 kinase pathway","volume":"15","author":"Parsons","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib57","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1128\/MCB.20.14.5010-5018.2000","article-title":"Phosphorylation of the PTEN tail regulates protein stability and function","volume":"20","author":"Vazquez","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-10-2488","article-title":"PTEN level in tumor suppression: how much is too little?","volume":"71","author":"Carracedo","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib59","first-page":"390","article-title":"Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells","volume":"87","author":"Kay","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.ajpath.2011.06.017_bib60","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1158\/0008-5472.CAN-05-1888","article-title":"Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis","volume":"65","author":"Chung","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib61","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1128\/MCB.25.14.6211-6224.2005","article-title":"Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation","volume":"25","author":"Liu","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1242\/jcs.022459","article-title":"The nuclear affairs of PTEN","volume":"121","author":"Planchon","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2011.06.017_bib63","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI119804","article-title":"Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus","volume":"100","author":"Kedes","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2011.06.017_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/viro.1997.8822","article-title":"The KSHV\/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft","volume":"238","author":"Picchio","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.ajpath.2011.06.017_bib65","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/1078-0432.CCR-04-1857","article-title":"Inhibition of phosphatidylinositol 3\u2032-kinase\/AKT signaling promotes apoptosis of primary effusion lymphoma cells","volume":"11","author":"Uddin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib66","first-page":"2331","article-title":"Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1\/PTEN gene transfer","volume":"58","author":"Cheney","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib67","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.onc.1202441","article-title":"Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase","volume":"18","author":"Morimoto","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2011.06.017_bib68","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JVI.01757-06","article-title":"Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy","volume":"81","author":"Petre","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00002030-199405000-00002","article-title":"Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals","volume":"8","author":"Herndier","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2011.06.017_bib70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00002030-199706000-00003","article-title":"The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line","volume":"11","author":"Albini","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2011.06.017_bib71","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/87.13.974","article-title":"Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma","volume":"87","author":"Lunardi-Iskandar","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2011.06.017_bib72","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/JVI.80.10.4833-4846.2006","article-title":"Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo","volume":"80","author":"An","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib73","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1158\/0008-5472.CAN-04-4180","article-title":"Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum","volume":"65","author":"Wlodarski","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib74","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.080068597","article-title":"The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders","volume":"97","author":"Majewski","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.06.017_bib75","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.transproceed.2007.11.072","article-title":"Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus","volume":"40","author":"Kaposztas","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajpath.2011.06.017_bib76","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1535-7163.MCT-10-0833","article-title":"Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma","volume":"10","author":"Cen","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajpath.2011.06.017_bib77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10637-009-9269-x","article-title":"The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines","volume":"28","author":"Ma","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ajpath.2011.06.017_bib78","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ajh.21216","article-title":"mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)","volume":"83","author":"Holtan","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/8.2.185","article-title":"PTEN is inversely correlated with the cell survival factor Akt\/PKB and is inactivated via multiple mechanisms in haematological malignancies","volume":"8","author":"Dahia","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2011.06.017_bib80","first-page":"642","article-title":"Role of the phosphatidylinositol 3\u2032-kinase\/PTEN\/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells","volume":"62","author":"Van de Sande","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib81","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/MCB.23.17.6139-6149.2003","article-title":"PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1","volume":"23","author":"Radu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib82","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2009.007260","article-title":"Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1\/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma","volume":"94","author":"Boulanger","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ajpath.2011.06.017_bib83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.MP.0000067423.83712.74","article-title":"Analysis of the PI-3-kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray","volume":"16","author":"Abbott","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib84","doi-asserted-by":"crossref","first-page":"35195","DOI":"10.1074\/jbc.M503045200","article-title":"Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta","volume":"280","author":"Al-Khouri","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.06.017_bib85","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1128\/JVI.77.14.8019-8030.2003","article-title":"The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta","volume":"77","author":"Fujimuro","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib86","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9440(10)64901-2","article-title":"Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma","volume":"160","author":"Kang","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib87","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","article-title":"Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma","volume":"69","author":"Hino","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.06.017_bib88","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dal Col","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.06.017_bib89","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2011.06.017_bib90","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"27","author":"Hess","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2011.06.017_bib91","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI30945","article-title":"Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas","volume":"117","author":"Sarek","year":"2007","journal-title":"J Clin Invest"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011006341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011006341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:34:15Z","timestamp":1757601255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011006341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0002944011006341"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.06.017","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphatase and Tensin Homolog on Chromosome 10 Is Phosphorylated in Primary Effusion Lymphoma and Kaposi's Sarcoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}